Add BrightSurf on Google Email

Science News Archive September 2004 - Page 6


Page 6 of 12

Chemical genetics identifies SARS inhibitors

Chemical genetics was used to identify novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus. The study revealed four compounds that effectively inhibited the replication of the virus, providing new hope for the treatment of SARS.

SourceCell Press·JournalChemistry & Biology·DateSep 17, 2004

New technique for thyroid cancer therapy eliminates many side effects

Researchers in The Netherlands and Belgium developed a new technique that uses genetically engineered rhTSH to stimulate thyroid cancer cells to absorb radioactive iodine, avoiding hypothyroidism and increasing safety. This approach may allow higher doses of radioiodine to be used when needed, improving treatment efficacy.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateSep 17, 2004

A bacterial cause of Crohn's disease?

A study finds that 50% of patients with Crohn's disease have viable MAP in their blood, suggesting a systemic infection. The findings raise questions about the role of MAP in IBD and highlight the need for further research to clarify its significance.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 16, 2004

Food study finds diets get healthier over time

A new study suggests that most people's diets get healthier from childhood to young adulthood. Adults tend to consume more fruit and vegetables and less fat and sugar compared to their child years. However, many people perceive barriers to healthy eating, such as lack of time and work patterns.

SourceNewcastle University·JournalAppetite·DateSep 16, 2004

Humans not irrational, just wary

Researchers developed a new trust model to interpret subjects' performance in a simple task. The model factors in doubt and found that many students expressed doubt despite being told it was unlikely. This challenges the assumption that humans are irrational when doubting instructions.

Glass research earns Lehigh a coveted NSF award

The Lehigh International Materials Institute (IMI) will receive $3.25 million to develop new glass functionalities and foster global collaboration. The grant aims to revitalize the worldwide glass research community and educate a new generation of experts, addressing concerns about the US losing its lead in the field.

Venn diagram tactics to vet complex disease

A study using Venn diagram tactics categorizes mutation types in cells from different patients, identifying a novel cause of lethal neonatal mitochondrial complex I deficiency. The authors demonstrate the technique's strength by pinpointing mutations in the NDUFS6 gene, a previously unknown contributor to this disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 15, 2004

JCI table of contents September 15, 2004

Researchers develop methodology to efficiently pinpoint mutations in mitochondrial respiratory chain, identifying new cause of lethal neonatal disease. The technique uses cell-fusion experiments and bioinformatics analyses to categorize mutation types, revealing complex genetic backgrounds.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 15, 2004

A one-two punch for tumors

Researchers found that combining histone deacetylase inhibitors with anti-angiogenesis drugs reduced tumor growth in mice by up to 85% and controlled new blood vessel formation by 60%. This combination therapy may provide a greater impact on cancer development than using the drugs alone.

SourceJohns Hopkins Medicine·JournalCancer Research·DateSep 15, 2004